Condition

Advanced Gastric Cancer clinical trials and research

• 15Clinical trials
• 4Countries

Newest Advanced Gastric Cancer clinical trials

All recruiting trials (15)

• Predicting Immunotherapy Response in Advanced Gastric Cancer using PET Imaging

  This study tests whether FAPI PET/CT and Grazytracer PET/CT can predict how advanced gastric cancer will respond to preoperative immunotherapy-based treatment.

  Recruiting Ruijin Hospital · Shanghai · NCT07824479

• Adding 2141-V11 to standard therapy for advanced esophageal, gastric, or gastroesophageal junction cancer

  This study tests whether adding the drug 2141-V11 to standard anti-PD-1 therapy (with or without 5-FU) is safe for adults with advanced or metastatic esophageal, gastric, or gastroesophageal junction adenocarcinoma.

  Recruiting at 7 sites Phase 1/2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07818018

• Low-leucine diet with chemotherapy and immunotherapy for advanced stomach cancer

  This will test whether a low-leucine diet helps people with advanced gastric cancer respond better to combined chemotherapy and immunotherapy.

  Recruiting Phase 2 Qilu Hospital of Shandong University · Jinan, Shandong · NCT07537348

• BHB810 in advanced gastric and GEJ cancer (early-phase)

  This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.

  Recruiting at 2 sites Phase 1/2 BigHat Biosciences, Inc. · Duarte, California and 2 other locations · NCT07529808

• Managing chemotherapy side effects with a smartphone symptom app plus telenursing

  This trial tests whether a smartphone symptom-reporting app combined with a standardized telenursing program helps adults starting first-cycle chemotherapy for gastric, lung, breast, or colon cancer manage treatment side effects.

  Recruiting at 4 sites Ulsan University Hospital · Busan and 4 other locations · NCT07405931

• QL1706 (Iparomlimab + Tuvonralimab) with SOX chemotherapy for untreated advanced or metastatic gastric or gastroesophageal junction cancer

  This trial will test whether adding QL1706 (two immunotherapy drugs) to SOX chemotherapy helps people with previously untreated advanced or metastatic gastric or gastroesophageal junction cancer get a better tumor response.

  Recruiting Phase 2 Beijing Friendship Hospital · Beijing, Beijing Municipality · NCT07315854

• XH001 plus personalized neoantigen vaccine–induced T-cell therapy for advanced stomach cancer

  This trial tests whether combining XH001 with a personalized neoantigen vaccine and vaccine-induced tumor-specific T cells is safe and can shrink tumors in adults with advanced gastric (stomach) cancer.

  Recruiting Phase 1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07298200

• PD‑1/TGFβ immunotherapy combined with either an EZH2 blocker (SHR2554) or apatinib plus chemotherapy for first‑line advanced stomach cancer

  This tests whether adding an EZH2 inhibitor (SHR2554) or the anti‑angiogenic drug apatinib to PD‑1/TGFβ immunotherapy plus CAPOX chemotherapy helps people with unresectable or metastatic stomach or gastroesophageal junction adenocarcinoma starting first‑line treatment.

  Recruiting Phase 2 The First Affiliated Hospital of Zhengzhou University · Zhengzhou, Henan · NCT07294664

• Finding better ways to detect resistance to antibody‑drug conjugates in solid tumors and identify useful biomarkers

  This trial tests whether tissue and blood biomarkers collected before and after treatment can reveal why antibody‑drug conjugates stop working in adults with advanced breast, gastric, urothelial, or non‑small cell lung cancer.

  Recruiting Phase 2 Unicancer · Villejuif · NCT07259226

• SHR2554 combined with other cancer medicines for advanced stomach or gastroesophageal junction adenocarcinoma

  This study will test if adding SHR2554 to other anti-cancer treatments helps people with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.

  Recruiting at 2 sites Phase 2 Jiangsu HengRui Medicine Co., Ltd. · Harbin, Heilongjiang and 1 other locations · NCT07102901

• HS-10502 combination treatment for advanced solid tumors

  This study will test whether the oral drug HS-10502, given with other cancer medicines, is safe and can help people with advanced solid tumors such as recurrent ovarian cancer, HER2‑negative or triple‑negative breast cancer, and advanced prostate cancer.

  Recruiting Phase 1 Jiangsu Hansoh Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality · NCT06769425

• Evaluating Zolbetuximab in Advanced Gastric Cancer

  This study is testing if a new drug called Zolbetuximab can help people with advanced gastric cancer who have a certain type of tumor, by looking at how well it works and what side effects it might cause.

  Recruiting Yonsei University · Seoul · NCT06767449

• Collecting real-world data on trastuzumab-deruxtecan for advanced gastric cancer

  This study is collecting real-world information from patients with advanced gastric cancer who are being treated with trastuzumab-deruxtecan to see how well the treatment works and how it affects their lives.

  Recruiting Yonsei University · Seoul, Seoul · NCT06767436

• Using immunotherapy and chemotherapy for advanced gastric cancer treatment

  This study is testing if combining immunotherapy with chemotherapy can help people with advanced gastric cancer feel better and improve their treatment outcomes.

  Recruiting Qilu Hospital of Shandong University · Jinan, Shandong · NCT06727981

• Using fecal microbiota transplantation to treat advanced gastric cancer

  This study is testing if giving patients with advanced gastric cancer special capsules made from healthy gut bacteria, along with their regular cancer treatments, can help them feel better and improve their chances of recovery.

  Recruiting Changhai Hospital · Shanghai, Shanghai Municipality · NCT06346093

Related topics

Quick answers

How many Advanced Gastric Cancer clinical trials are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (9 trials), South Korea (3 trials), United States (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1/2: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →